Market Overview

The Pet Arthritis Treatment Market was valued at approximately USD 3.5 billion in 2025 and is projected to reach around USD 7.1 billion by 2035, registering a CAGR of 7.4% during 2026–2035. The market includes non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying osteoarthritis treatments, nutraceuticals and supplements, corticosteroids, viscosupplementation, regenerative therapies, and physical therapy solutions used to manage arthritis and degenerative joint conditions in companion animals. Increasing cases of osteoarthritis among aging pets, rising expenditure on veterinary healthcare, greater awareness of early diagnosis, and growing demand for long-term mobility and pain-management solutions are supporting market growth.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/pet-arthritis-treatment-market-57691

Market Growth Drivers

The increasing prevalence of osteoarthritis and degenerative joint disorders among aging dogs and cats is a major factor driving the market. As companion animals live longer, age-related mobility and joint problems are becoming more common, increasing demand for effective long-term treatment. Pet humanization is another important driver, as owners increasingly prioritize their pets' health, mobility, comfort, and quality of life. Growing awareness of early diagnosis, preventive veterinary care, weight management, physical rehabilitation, and nutritional support is further increasing demand for arthritis-management products and services.

Key Market Trends

The market is increasingly moving toward multimodal and personalized arthritis management, combining medication with nutritional supplements, physical therapy, exercise, weight management, and mobility support. Advanced approaches such as regenerative medicine, biologic therapies, viscosupplementation, and targeted treatments are gaining attention as complementary options to conventional medication. There is also increasing demand for joint-health supplements containing ingredients such as glucosamine, chondroitin, omega-3 fatty acids, and other nutritional compounds. Digital veterinary services and wearable monitoring technologies are also creating opportunities for continuous monitoring of pet mobility and treatment progress.

Regional Insights

North America

North America represents a major market due to high pet ownership, significant spending on veterinary healthcare, developed veterinary infrastructure, and strong awareness of pet wellness. Pet owners are increasingly seeking early diagnosis and long-term management of arthritis, supporting demand for medications, joint supplements, physical rehabilitation, and advanced treatment options. The United States remains a particularly important market for veterinary pain management and companion-animal mobility solutions.

Asia Pacific

Asia Pacific is expected to experience strong growth as pet ownership, disposable incomes, veterinary infrastructure, and awareness of animal healthcare continue to increase. China, Japan, South Korea, and India represent important opportunities as pet owners increasingly invest in preventive healthcare and treatments that improve the mobility and quality of life of aging animals. Growing access to veterinary clinics, pet pharmacies, online pet-health platforms, and specialized treatments is further supporting regional development.

Europe

Europe is an important market supported by established veterinary healthcare systems, increasing awareness of animal welfare, and growing expenditure on companion-animal healthcare. Demand for preventive joint care, arthritis medications, nutraceuticals, physical rehabilitation, and advanced mobility treatments is expected to remain strong. Increasing focus on improving the quality of life of senior pets is also creating opportunities for specialized arthritis-management solutions.

Latin America

Latin America represents an emerging opportunity as pet ownership, veterinary awareness, and expenditure on companion-animal healthcare increase. Improving veterinary infrastructure and expanding access to pet pharmacies and online distribution channels are supporting demand for arthritis treatments and joint-health supplements. Brazil and Mexico are particularly significant markets in the region.

Middle East & Africa

The Middle East & Africa market is gradually developing with increasing pet ownership, improving veterinary infrastructure, and greater awareness of companion-animal healthcare. Growing interest in preventive veterinary care, premium pet wellness, and long-term management of age-related conditions is expected to create additional opportunities for arthritis treatment products and services.

Market Challenges

The market faces challenges related to the high cost of advanced arthritis treatments, limited access to specialized veterinary services, and affordability concerns in emerging economies. Long-term treatment can also create financial pressure for pet owners, particularly when advanced therapies, rehabilitation, or surgical interventions are required. Differences in veterinary healthcare infrastructure and awareness across developing markets may further limit adoption.

Market Opportunity

Significant opportunities are emerging across pet osteoarthritis treatment, canine arthritis treatment, feline arthritis treatment, pet joint supplements, veterinary pain management, regenerative medicine, biologic therapies, mobility-support products, and personalized pet healthcare. The combination of an aging pet population, increasing pet humanization, rising veterinary expenditure, and growing focus on pet quality of life is expected to support continued market expansion through 2035.

Related Reports:

Embedded Finance Market

Edge Computing Market

Digital Product Passport Solutions Market

Deepfake Detection Technology Market

Decentralized Identity Solutions Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co